Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Randomized Clinical Trial
81%
Sequential Analysis
80%
Cardiovascular Disease
78%
Cardiovascular System
75%
Systematic Review with Meta-Analysis
73%
Systematic Review
72%
Blood Pressure
53%
Meta-Analysis
46%
Cohort Analysis
44%
Congestive Heart Failure
43%
Adverse Event
39%
Cardiovascular Risk
37%
Placebo
36%
Biological Marker
32%
Quality of Life
32%
All Cause Mortality
31%
Systolic Blood Pressure
26%
Randomized Controlled Trial
23%
Atrial Fibrillation
21%
Patient with Type 2 Diabetes
21%
Clinical Trial
18%
Diabetes
17%
Brain Natriuretic Peptide
17%
Apoplexy
16%
Amino Terminal Sequence
16%
Birth Weight
16%
Physical Activity
15%
Prevalence
14%
Hazard Ratio
14%
Aortic Stenosis
14%
Primary Health Care
14%
Blood Pressure Measurement
14%
Body Weight
13%
Body Mass Index
13%
Postoperative Pain
12%
Insulin Sensitivity
12%
Kidney Function
12%
Coronary Artery Disease
12%
Diseases
12%
Proportional Hazards Model
11%
Clinician
11%
Malignant Neoplasm
11%
Patient with Hypertension
11%
Osteoporosis
11%
Antidepressant
11%
Pulse Wave Velocity
11%
Paracetamol
10%
Sepsis
10%
Intima-Media Thickness
10%
Proton-Pump Inhibitor
10%
Cell Function
10%
Arterial Stiffness
10%
Intensive Care Unit
10%
Cardiovascular Mortality
10%
Type 2 Diabetes
10%
Ibuprofen
10%
Prospective Study
10%
Urokinase Receptor
10%
Volunteer
10%
Left Ventricular Hypertrophy
9%
Myocardial Infarction
9%
C Reactive Protein
9%
Risk Stratification
9%
Sildenafil
9%
Gastrointestinal Bleeding
9%
Total Knee Arthroplasty
9%
Hamilton Rating Scale for Depression
9%
Delirium
9%
Dexamethasone
9%
Chronic Obstructive Pulmonary Disease
9%
Low Carbohydrate Diet
9%
Dexmedetomidine
9%
Osteogenesis Imperfecta
9%
Stress Ulcer
9%
Neonatal Sepsis
9%
Fetus Growth
9%
Out of Hospital Cardiac Arrest
9%
Hypothermia
9%
Calcitonin Gene Related Peptide
9%
Migraine
9%
Monoclonal Antibody
9%
Absorptiometry
9%
Electrocardiogram
9%
Health Care Cost
8%
Low Birth Weight
8%
Arm
8%
Ischemic Heart Disease
7%
Echocardiography
7%
Major Depressive Episode
7%
Personalized Medicine
7%
Brain Injury
7%
Diastolic Blood Pressure
7%
Dextromethorphan
7%
Health System
7%
Comorbidity
7%
Vascular Disease
7%
Subgroup Analysis
6%
Morphine
6%
Gestational Age
6%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
66%
Congestive Heart Failure
65%
Cardiovascular Disease
64%
Adverse Event
62%
All Cause Mortality
59%
Non Insulin Dependent Diabetes Mellitus
54%
Cohort Study
54%
Cardiovascular Risk
53%
Placebo
41%
Biological Marker
32%
Heart Infarction
27%
Atrial Fibrillation
26%
Brain Natriuretic Peptide
23%
Cardiovascular Mortality
20%
Intervention Trial
19%
Cerebrovascular Accident
18%
Diseases
18%
Beta Adrenergic Receptor Blocking Agent
17%
Coronary Artery Disease
17%
Clinical Trial
16%
Sepsis
15%
Randomized Controlled Trial
15%
Ischemic Heart Disease
14%
Delirium
14%
Aortic Stenosis
14%
Malignant Neoplasm
12%
Bisphosphonic Acid Derivative
11%
Antihypertensive Agent
11%
C Reactive Protein
11%
Antibiotics
10%
Proton Pump Inhibitor
10%
Normal Human
10%
Replacement Therapy
10%
Chronic Kidney Failure
9%
Inflammation
9%
Comorbidity
9%
Heart Atrium Flutter
9%
Dexmedetomidine
9%
Newborn Sepsis
9%
Tramadol
9%
Gastrointestinal Hemorrhage
9%
Migraine
9%
Monoclonal Antibody
9%
Calcitonin Gene Related Peptide
9%
Anticoagulant Agent
9%
Cannabinoid
9%
Acute Heart Infarction
8%
Low Birth Weight
8%
Heart Arrhythmia
8%
Eating Disorder
7%
Heart Left Ventricle Hypertrophy
7%
Heart Failure with Reduced Ejection Fraction
7%
Combination Therapy
7%
Risk Evaluation
7%
Urokinase Receptor
7%
Remission
7%
Hip Fracture
7%
Triacylglycerol
7%
Prevalence
7%
Hypotension
6%
Dexamethasone
6%
Valsartan/Sacubitril
6%
Antidiabetic Agent
6%
Chronic Pain
6%
Creatinine
6%
Enkephalinase Inhibitor
5%
Anorexia Nervosa
5%
Dextromethorphan
5%
Troponin T
5%
Cancer Pain
5%
Glucocorticoid
5%
Paracetamol
5%
Postoperative Pain
5%
Liver Cancer
5%
Diabetes Mellitus
5%
Heart Muscle Ischemia
5%
Enteritis
5%
Peptoclostridium difficile
5%
Natriuretic Factor
5%
Interleukin 6
5%
Simvastatin
5%
Ezetimibe
5%
Coronary Risk
5%
Prospective Study
5%
Fragility Fracture
5%
Statin (Protein)
5%
Framingham Risk Score
5%
Nursing and Health Professions
Blood Pressure
63%
Non Insulin Dependent Diabetes Mellitus
37%
Cardiovascular Disease
33%
Systematic Review
23%
Systematic Review with Meta-Analysis
20%
Cardiovascular Risk
19%
Systolic Blood Pressure
18%
Adverse Event
18%
Sequential Analysis
17%
Confidence Interval
15%
Practice Guideline
14%
Meta Analysis
14%
Delirium
14%
Pressure Control
11%
Congestive Heart Failure
11%
Quality of Life
11%
C Reactive Protein
10%
Telehealth
9%
Body Weight
9%
Primary Medical Care
9%
Patient with Hypertension
9%
Inflammation
9%
Dexmedetomidine
9%
Brain Natriuretic Peptide
9%
Biological Marker
9%
Body Mass
8%
Antidepressant
8%
Diseases
8%
All Cause Mortality
8%
Placebo
8%
Major Depression
7%
Oxygenation
7%
Blood Pressure Measurement
7%
near Infrared Spectroscopy
6%
Sepsis
6%
Dual Energy X Ray Absorptiometry
5%
Cohort Analysis
5%
Volunteer
5%
Pulse Wave
5%
Brain Injury
5%
Body Composition
5%
Cost Effectiveness Analysis
5%
Predictive Value
5%
Combination Therapy
5%
Correlation Coefficient
5%
Coronary Artery Disease
5%
Triacylglycerol
5%